PEPFAR Quality Control and Method Validation Activity 6: Part 1

Type number sampks 3) QC used number Of QC samples ±es+ed Type-and number of CC sompks number Type and number sampks tes+ed 3 Type number samples +es+ed Type-and number of QC sampks tes+ed Type and number of QC sampks fes+ed 2) Type number of QC samples +es+ed 3 Type numbec of GC sampks 2) Type number Of sampks ±esfed i 3 Type number of QC sampks fes+ed Type and number Of QC sampks fes+ed ype and number Of Q sampés ±es+ed ype avid number sampks ±es+ed samples ype and number of QC sampks ±es+ed and number of fes+ed and number Of QC sampks +es+ed ype and number Of GC sampks ±fes+ed ype and number QC sampks fes+ed number of QC sampks ±es+ed s fed S used +0 Frequency S used used used •to sea to •Analytical shall be periodically ex number or purpose possible to patie ot snail D shall be per snail snail P De Type and number of QC ±es+ed Type anid number of QC sampks ±es+ed Type and number samples fes+ed Type-and number of QC samples fes+ed Type number of QC sampks ±es+ed Type avid number of QC sampks fes+ed Type and number Of QC sampkes tes+ed QC used +0 and number fres+ed Type and number sampks fes+ed Type and number sampkes fes+ed Type and number Of QC samples +es+ed Type and number of QC samples +esfed Type number Of sampkes fes+ed Type and number of QC sampkes +es+ed Type number Of GC samples +es+ed Type and number of QC sampks ±es+ed ype numbec Of QC sampks Type number Of QC sampks +esfed Type and number of (AC sampks ±esfed 2) Type number of QC sampks +es+ed Type number of QC samples Type auid number of GC sampks ftesfed used +0 2) Type number sompes ±es+ed we and number of sampks ±es+ed Analytical 2) Type number of GC 2) Type number Of sompks Frequency used used 40 2) Type and number of GC ±es+ed possible to patient sa To list the steps number Of sompks fes+ed C used and number Of sampks +es+ed number avid number Of Q SAmpks number Of sampks tes+ed ype and number of GC sampks ±es+ed ype number of QC samples Type and number of QC sampks ±es+-ed ype and number Of QC sampks fes+ed ype numbec Of QC sampks fes+ed Type and number tf ±es+ed ype number Of QC sampks ±es+ed ype and number sampks tested ype and numbec Of (X sampks tes+ed used used +0 Type and number of GC samples ±es+ed and numbec Of sampks •fesfed number Of QC sampks +es+ed Type and number sampks ±es+ed Type and number of QC sampks tes+ed C used ype number QC sampks fes+ed ype number of sampks ype number of QC sampks ies+ed used -ho number sampks tes+ed Type•and number of QC sampks -es+ed ype and number of QC sampks fes+ed ype number Of sampks fes+ed we number Of sampks fesfed ype number Of QC sampks tes+ed ype and number of QC sampks ype and number Of sampks ±es+ed we number of samples fes+ed number sampks ±es+ed ype and number Of sampks ype number Of sampks ±es+ed Type and number of QC sampks +es+ed Type avid number of QC sampks ±esfed Type number sampks fes+ed Type number sampks +es+ed Activity: Parallel Testin used +0 System and number samples fes+ed 2 Type number Of ±es+ed number sampks •fes+ed • n number OfQC sampks ±es+ed number samples fes+ed and number Of sampks tes+ed — Tested by manufacturer usin 2 Type number of sampks 2 Type and number of QC sampks fesfed 2 Type number sampks +es+ed C used +0 C used +0 possible to patient sar Type number fC sampks ±esfed System and number Of sompks fesfed Produce number used ype number sampks tes+ed 2 Type number sompks +es+ed Tested by manufactur€' ba used — Tested by ma Overview: Introducing a New Lot possible to patif — Tested by man Sf — Tested by manufacturer u: — Tested by manufacturer — Tested by manufacture Purpose — Tested by manufactt based possible to patient sample possible to patient samplE — Tested by manufacturer usi — Tested by manufacturer us Tested by manufacturer usi — Tested by manufacture! Tested by manufacture possible to patient samples possible to patient samples. — Tested by manufacturer using Tested by manufacturer To list the stepc How SOC Works possible to patient samples. Quality cc possible to patient samples. Qual used possible to patient samples. Quality con Frequency of even+s To list the steps shall be periodically examined with a shall be periodically examined with a fre based on the 3) QC used +0 possible to patient samples. Quality cor based on th shall be periodically examined with a fi shall be periodically examined with a fiec shall be periodically examined with Job Aid I: Selectin A ro riate QC Material 606 l) Frequency OF even+s To list the steps nece The of revtew for Analytical 3) QC +0 based on the stab 3) QC q) The of periodic revtew System perform parallel 3) QC 45ed multiple methods bef01e shall be periodica used +0 3) QC used +0 3) QC 40 QC ased QC used evalua+e QC +0 QC use-d of periodic review based on the sta QC used +0 QC ased +0 QC used When Do You Create a New LJ ISO 15189 5.6.2.2 Quality control materials QC used +0 QC ase-d QC Ulsed {o QC used QC (Ased QC used +0 QC used 40 shall be periodic IA) of periodic vevtew QC used {o based on the stability o 9) ased shall be periodically e Ase-d +0 QC ased used +0 used QC The of revtew used The of pertodic review for of review ased +0 ased 40 used used Quality The of periodic review The of peviodlC review for The OF periodic review evaluA+e The of periodic review for To list the steps necess Quality used used multiple met] The OF peVlOdic review multiple rnet used +0 Commercially Prepared Controls multiple meth multiple methods befo1e multiple methods befo multiple methods befc multiple methods before s multiple methods before multiple methods bef01 assalyzed ansalyzed 2) Type number sampes multiple methods befor€ se multiple mnethods before sa multiple methods before sale Type number Of sompes number shall be periodic" q) of review evalua+e q) OF periodic revtew shall be periodically examir l) Frequency of (AC shall be periodically examined witt shall be periodically examine( wi shall be periodically exam shall be periodically examined with a uased shall be periodically examined with a fr I Frequency OF QC We OC perform paralle 3 Type and number of GC sampks +es+ed shall be periodically examined witl Quality shall be periodically examined with a frec used Quality shall be periodically examined with a fro The revtew 3) Quality The of Tevtew The of review multiple The of pevtodic review The of peviodtc revtew System I-I) The of pevtodiC revtew The OF pevtodtc revtew for The OF review for The of periodic revtew The of periodic vevtew for OF pevtodlC review based on the stability of the procedurc based on the stability of the procedut based on the stability of the procedure a 3) presented The of peciodic review for Quality The revtew The OF pevtodic review based on the stability of the procedu harm to the The of periodic review for The of pertodic review Quality based on the stability of ty based on the stability of the procedure al presented durin€ The OF periodic revtew analyzed analyzeda evalua+e harm to the patie To list the steps nece: harm to the pati Laborator q) of periodic Tevtew presented durinf The of review What will you based on the stab Purpose The OF periodic revtew for The of peviodic revtew of peviodlC revtew Other words. we based on the sta harm to the p defec+in and +ceods QC used evalua+e perform parallel +0 Goals harm to the patient frorr Number into Service 1-1) The of periodic revtew QC Materials q) The of periodic review used +0 used Laborator evalaa+e Goals The of review The of periodic review for harm to the patier You work individually The OF revtew perform parallel testing Activity: Parallel Testing Role Play q) of pevtod,c revtew The OF periodic review Sold with res q) The of periodic review Laborator Goals Quality review Sold with resc q) The of review q) The OF review Type and number Goals What Will you of periodic review q) The periodic review q) The of pericdlC review for Sold with results of thi q) OF periodic review defec+in and +rends de ecåinj and *rends q) The revtew Sold with results of the based on the st; Quality q) The of pevtod,c review q) The OF pevicd.c review l) The of review q) The OF petiodic review for Il) The revtew — Sold with results of 'the NOTE The 09 pevtodlC review q) The of periodic review for The of pectodic Teuew q) The of pevicdiC Teview q) The penodtc review OF PevtodiC review de — Sold with results of the Quality Quality only Quality Quality q) The of peviodjc review q) The OF periodic review for q) The review q) The of review and +cends Quality and s and *rends based on the stability of the p based on the stability of the based on the stability of th and +rends q) OF periodic review for The OF peviodlC revtew for defecfån Goals based on the stability of the proco ro Quality The OF pevtodtc review for The of review for The OF revtew and *rends based on the stability Goals QC used based on the stability of the procedure presented durir based on the stability of the proce Laboratory Monitor 'orator 1-1) of petiod,c review Laboratory based on the stability of the procedure a The of The OF review q) The of pericdac review Goals The of periodic and +cends Laborator The of fevtew The of Teview for The of pevicdjc revtew ID of review The The of peciodic review q) The of pevtodic review The pericdjc review Morator The 09 Tevtew The Of review for The Of review The of revtew q)e of periodic review The The OF peviod.c review for The review The of periodic review The OF periodic review l) The of periodic review q) The OF periodic review .2 The of peviodic review for The OF periodic review for q) The of pertodic review q) The of periodic revtew for Laborator Il The of tevtew The pevtc,dtc review The of pevtodic review for The of peviodic review of periodic review harm to the patient from an erroneou harm to the patient from an erroneous r The laboratory shall use quality control materials that defec+inj defecfinj and Monitor To list the steps necessary to defecfinj a harm to the patient 'from an erroneous harm to the patient 'from an erroneo evalua+e harm to the pati Mimic the matrix and viscosity The 09 peviodic review for defec±lnj defec±lnj a of pevtodic review harm to the patient from an erroneous re q) The of periodic revtew The of pevicdrc teview defecfinj an 09 peviodlC teview for and defec+inj and +cends defec+unj and {rends The of pecicdic review -is presented during the r Laborator review harm to the patient fro borator Results periodic review Iaborator Laboratory NOTE 1 The defec+inq and *rends and +reMs b) review Goals defeciinj and +cends defecåanj and +cends defecfjnj and +cends b) The achons ±aKen when and and +rends n and +cends NOTE 1 The labo Goals and *rends The of periodic review NOTE 1 The lab Goals Goals and *rends b) The ac+ions +ahen when resul+s testing 'orator Goals and +rends b) The achons fQ6en b) The achons when re The Tevtew Quality Goals The of periodic rev:ew for defechnj and *rends The rev.ew and +cends Results and and +cends Goals Chart? presented during the a. Matrix Which and +cends To list the steps to 'Laborator b) defec+inj and q) The revtew q) The periodic r-evtew q) The pevicdtc revtew q) The r-evtew testing Goats defec+inj b) The achons +ahen when testing Results testing Quality de+ec+inj and +rends ults esults i Laborator review ahen when resul+s harm to the patient from an errone harm to the patient 'from a harm to the patient from defec+nj and *rends harm to the patie Laborator Laborator defec±inj ISO 15189 5.622 Quality control materials harm to the patient from an erron harm to the patient 'fro sults ISO 15189 Quality control materials The periodic r•evtew The The revtew evaluoVe NOTE 1 The laborator b) The ac+ions ±Qhen b) The achons +QKen when only b) The achons +ahen harm to the patient 'from an erroneous re harm to the patient from an erroneous harrn to the patient from an errone harmn to the patient from an errone and +rends review b) The achons fQ6en when resul+s b) The achons wahen b) The achons fQ6en Overview: Introducing a New Lot Overview: Introductng a New Lot Results b) The achons +aKen defecfinj and *rends when resul+s b) The achons fa16en when defec+inj and Jr.-ends defec+inj and +ce defec\inj and +rend>_ defecåinj and +cends defec±inj and + defec*inj and The review ±Qhen when resul+s Its Results defecfinj and *rends detec+inj and +rends detec+inj and *rends defeciinj defecfinj and +cends defec±inj and +cends and How SQC WorkS SOC defecflnj defec+lnj defec+inj and + defecfinj and +rend. defec+inj Q and *rends and +ceods 'esuits defec+inj and defec+inj an defec+inj and +rends defecfinj and +rends defec±inj and +rends defec\inj and esults defec+inj and *reeds defeciinj and defec+inj and +cend results Quality b) The when defec+inj s and *fends nS when resul+s b) The achons ±Qhen when b) The achons when he analy+ical b) The achons ±QKen when defecåinj an and d and +rends and +cends d +cends defeciinj a, ec+inj and +rends assayed • Assayed . Assayed b) The achons when resul+s b) The achons +Q6en when re defec+inj and *rends and +cends and • Unassayed • Assayed . Assayed and +rends la and and A-rends and *fends — Common formats use defec+inj and +cends ± +QHen when resul+s .4 Commercially Prepared Controls and *rends and +rends and +rends and +cends fid +cends Results control n and +cends and and and +ce Goals and +r and -s and *rends b) The achons fahen when Goals Activity• Parallel Testing Role Play b) The achons +Q6en when resul+s NOTE 1 The lab NOTE 1 The laboratory should choc b) The achons fahen when res„l+s b) The achons Quality analy+ical Analytical NOTE 1 The laboratory should choo: b) The achons ±Q14en when Goals NOTE 1 The laboratory should choo 'i NOTE 1 The laboratory should choos NOTE 1 The laboratory should cho ±Qhen when resu14s b, and Results esults ns when when Laborator S when resul+s NOTE 1 The laborato — Common forr b) The achons +QHen when resul+s NOTE 1 The laboratory s NOTE 1 The defec+inj and Results react to the examining system in a manner as close as Number into Service exceed b) AA achons b) The achons +Qhen when re b) The achons ±ahen when control materials — Common form b) The achons +QBen when b) The ad-ions +Qhen when resul+s b) The achons b) The achons ±Q64en b) The achons +0 hen wh b) The achons ±Qhen b) The achons +Qh4en b) The achoos ±ahen$ during the role play and +rend3 Laborator b) The achons +a6en when b) The achons wh b) The achons ±Qhen when resul+s control mate b) The achons ±Q6en when resul+s b) The when resul+s b) The achons ±a6en when resul+s b) The achons +Q16en when resul+s b) The achons +Q6en b) The achons ±Q6en b) The achons whe b) The achons +Qhen when b) The achons whKen b) The achons +Q6en whe exceed OCCept061e and *rends — Common forrnats used defecfinj and +reM3 control materials, and and +rends b) The achons ±Qh6en when r b) The achons ±Q6en when b) The achons +Q6en when resul+s b) The achoos +Q6en when re b) The achons +Q6en when, b) b) The achons +Q6en when r b) The achons +Q6en when — Common formats used witl Common formats used Common formats used wit — Common formats used with — Common formats us b) The achons b) The achons ±Qh4en b) The achons ±hen b) The achons ±Q14en b) The +QI•6en when resul+s b) The achons +Q16en b) The achons wh6en b) The achoos when resul+s b) The +Q16en when resul+s b) The achons ±QK6en when resul+s b) The achons +Q6e b) The achons fahen when resul+s b) The achons fQ16en b) exceed defec+n and *rends Common formats used with Common formats used witl — Common formats used and +cend3 b) The achons ±QKen b) The b) The achons ±a6en when acceptable esults b) The achons +QKen when resul+s b) b. Quality 5) The ac+ions +aKen control materials The achons +Q6en when resul+s Results control materials, wher b) The achons ±hen b) The achons when l) control materials, whereve What will you nem achons +QKen res-d+s b) The achons ±Q16en when resul+s b) b) The achons when resul+s What will you do? b) The achons ± l,) Frequency ns ±Qhen when resul+s S ±Qhen when resul+s presented the Frequency NOTE 1 The I Y,) The when resul+s The achons when NOTE 1 The laboratory What will you n Should d Should System achons +Q64en when resul+s . Hons ±Q6en when +Ql•6en when resul+s .S ±Q16en when resul+s KQhen when resul+s Frequency c; Frequency c: +Q6en when resul+s C; b) The achons ±ahen when eons when resul+s c; when cesul+s NOTE 1 The laboratory should ch NOTE 1 The laboratory should b) The achons +a%en when b) The achtons when resul+s achons NOTE 1 The laboratory should choose NOTE 1 The laboratory should ct Hchons ±QKen when resul+s exceed . e sul+s Goals Goals when resul+s b) The achons when re L hons ±Qhen when Hons ±Qhen when resul+s Q16en when resul+s and +rends b) The achons +aKen when resul+s b) The when resul+s b) The achons +Q6en resul+s VOu when resul+s resul+s exceed qccepfüle exceed esults exceed occep+oble exceed accept exceed I en when resul+s when saws • Assayed Assayed Aessayed . Assayed exceed b) The achions +a6en exceed qccep+' exceed exceed accep+oble b) The achons when exceed QCQep+aåle and +reods other methods while still producing consistent results on patient samples exceed acceptable exceed Goals Punose Purvose exceed occeptüle Purpose exceed package insert control materials, wherever possible control materials, wherever possiblf What will you esults number control materials, wherever possible, control materials, wherever possibl package inserts Purpose control materials, exceed OQQep+oCle exceed QCQep±oåIe package inserts near clinical near clinical deci b) The achons ±Qhen when What will you need? near WHERE WE ARE exceed Il exceed OCCep+061e exceed l, exceed OQQep%61e exceed occep+oåle exceed accep+able exceed I '5 •xceed nxceed exceed accept-ruble exceed OCCep%61e exceed OCQep±oåIe exceed OCCep+ohule — Tested by manufacturer using Tested by manufacture — NOT tested by manufacturer — Tested by manufacturer using exceed exceed occep+oble exceed accep+able exceed exceed OQQeptoåIe exceed OQQep+061e exceed OCQep+061e exceed OCCeptokJIe exceed acceptüble red exceed qccep+oåle exceed OCQep+061e•i exceed OCCep±üåle exceed QCQepf-061e exceed OCQeptohule exceed acceptoåle exceed acceptable exceed exceed - _ exceed exceed OQCep+oble Ixceed exceed accep+oåle exceed occep±r exceed d occep+061e exceed accep+oåie near clinical decision v Mean and possible to patient samples. Quality control materials exceed accep exceed Äceed OCCep+061e control materials, wherever p control materials SD obs exceed qceep+oåle OCQep+061e • exceed exceed OCQep+ohJIe Kceed used control materials, whereve control materials, wherev control materials, wherevf exceed QCept061e control materials, wh Lot changes exceed OQQepfoCIe control materials, wherever possible, es control materials, wherever possi exceed ice ed b) +2 SD samples You will work individually precision WHERE we EXPECT ro WHERE - What will you need, exceed What will you ne decisi same ma achons when Mean and ISD Mean and ±2 ions +Q6en when resul+s ro WHERE WE ARE near clinical decision valu Notepad near clinical ex ARE Mean and ± 2 SD range WHERE ARE near clinical decision Mean and SD range Mean and ±2 SD ram decision WHERE me Mean and ±2 SD range Mean and ±2 SD ramge WHERE ro . WHERE . Contain concentrations of analytes at or near medical decision points m ARE WHERE near clinical decision values, which we WHERE near clinical decis WHERE What will VOu need? MEAN obs WHERE ARE which near clinical decision values, which er near clinical decision values, which ers we ARE WHERE we ro exceed accept-able exceed OQQep+Q61e decisions m Quality we WHERE ARE shift, so exceed 10 - near clinical dec Notepad WHERE Mean and ±2 Sl WHERE we EXPECT ro ' WHERE WE EXPECrrOBE WHERE WE WHERE WE ARE WHERE we WHERE WE ARE wyeRE WE ro BE WHERE PECT ro BE' near clinical decision values, near clinical deci near clinical decision value WHERE ro WHERE WHERE WE EXPECT m WHERE WE ARE WHERE WE EXPECT ro WHERE WE ARE WHERE ARE WHERE WE ARE WHERE WE'. WHERE WE near clinical decision values, which en near clinical decision values, whi( WHERE we EXPECT ro BE WHERE we TO Be WHERE we EXPECT ro WHERE We WHERE we ro WHERE WE ro Be WHERE WHERE WEf WHERE RE decisions ma exceed WHERE -roae near clinical decision values, which ens exceed QQQep+Q61e To list the steps necessary to we EXPECT ro BE' we decisions made. multiple methods before sale multiple methods before multiple methods befo WHERE WE WHERE WE ro BE before sale - WEARE ARE ro BE' WHERE WE EXPECT ro BE' ro WHERE WE A Re WE EXPECT ro BE' R WHERE WHERE WHERE we EXPECT ro BE ' E EXPECT ro Mean and I SD exceed we ro WHERE WE RE WHERE WE ARE ro WHERE WE ARE ro WHERE WE ARE WHERE WE EXPECT WHERE WE ARC WE ARE WHERE WE EXPECr rc BE ' Mean and io WHERE WE ARE Goals only oats o als HERE WE ARE WHERE WE EXPECT ro BE Notepad ro WHERE WE AoE WHERE WC ro WHERE we EXPECr ro WHERE we ARE WHERE WE ro WHERE WHERE ro Be RE WHERE WE WHERE ee WC Mean and ± 2 WHERE WE cxpecr WHERE WE RE WHERE WE EXPECT ro WHERE WE Mean and SD WHERE ro WHERE WE ARE WHERE WHERE WE ARE WHERE WE EXPECT ro BE • WHERE WE ARE we WHERE WE ro WHERE WE ARE tA WHERE we ro WHERE WC Goats WE we ERE WE ARE WHERE WE EXPECT ro BE' WHERE shall be periodically examined with a frequency that is shall be periodically examined with a frec WHERE WC EXPECT WHERE WHERE WE WHERE WE RE WE WHERE we Mean and i SD Mean and I SD Mean and I. SD we TO WHERE WE ARE we EXPECT WHERE WE ARE WHERE we we WHERE WRE WHERE we ro we WHERE WE WHERE we WHERE WE expecr ro WHERE Mean and 1 SD WHERE m BE WHERE WE ARE WHERE ro WHERE WE WE ro WHERE WE ARE WHERE we —WHERE WE WHERE WE ARE WHERE we WHERE we ro WHERE WHERE ro WE A Re WHERE WE EXPECr ro BE' WHERE WE EXPEcr TO WHERE WE EXPECT ro WC Be WHERE WE ARE WHERE ro WHERE we ARE Be at different concentratior WE cxpccr ro WHERE WE ARE WE expecr WHERE WE ARE WHERE WE Be WHERE ARE WHERE WE WHERE ARE ro WHERE ARE WE me we we ARE WHERE we A Re expecr ro WHERE WE ARE WHERE we " WHERE WE EXPECT TO BE WHERE WE WHERE WE ro BE' —"HERE WE EXPECT ro WHERE WE EXPECT TO BE ' WHERE WE EXPECr ro BE ro ae WHERE WE ARE ro WHERE ARE ARE WHERE WE ARE WE WE EXPECT ro BE ' we ro we RE WHERE we A Re WHERE we TO we ro WHERE WE RE -cr Be WHERE WE RE .o WHERE WE ARE WE ARE WHERE we EXPECT ro ' Observe the role play we ARE Pen or pencil ro WHERE WC RE WHERE wr ro WC ARE Be WHERE WE RE WHERE WHERE WHE ARE WHERE ro we ARE - WE ARE WHERE WE ARE WHERE we ro ' SD ro WHERE we ro WHERE WHERE WE. ro WHERE WE ARE WHERE we A Re WE WHERE WE ARE WE ro WE ro BE', WE ARE WHERE WE ARE WHERE we ARE . WHERE WHERE WE ro DE' WHERE WE ro BE ' WHERE WE EXPECT ro BE' WHERE we -O WHERE we A Re WE m WHERE WE ARE WHERE WE expecr ro • WHERE WE ro ge WHERE WE EXPECr "E ' Mean —Controls (parallel testing) WHERE WE EXPECT ro 4 WE ARE we WHERE WE ro •S. we WHERE we ' WE EXPECT ro WE EXPECr ro WE EXPECT ' crro WHERE WE Notepad t WHERE we ARE WHERE WE ro BE WHERE WE expccr ro BE' WHERE WE ARE • WHERE i WHERE WHERE we roe WHERE WE EXPECr WE ro BE ro WHERE WE ARE WHERE we WHERE wE WHERE we EXPECT ro 'E WHERE we WHERE WHERE WRE WHERE WE WHERE WE TO BE w WHERE WE ARE WHERE WE ro WHERE we expecr ro ' WHERE we TO ' WHERE WE ro ' WHERE WE EXPECT ro BE WHERE WE expecr ro BE ' WHERE WE r. WHERE WE ro WHERE we roE ro WHERE WE ARE WHERE WHERE WE , WHERE we ro WHERE we EXPECT ro WE ro WHERE WE expecr ro WC Be WHERE WE ARE WHERE WE WHERE WE ro BE' WHERE WE EXPECr ro BE WHERE WE expecr ro BE' WHERE ARE WHERE WE RE WHERE WE expecr ro WHERE we EXPECT ro WHERE WE expccr TO WHERE WE EXPECT TO WHERE WE EXPECr ERE WE ARE WHERE WE EXPECr ro WERE we EXPECT ro i WHERE WE A RE WHERE we ARE WHERE WE ARE WHERE 'e ro WHERE ARE SD WHERE WE EXPECT ro ' WHERE WE ro BE' R WHERE WHERE WEARE WHERE WE RE YPECr ro WHERE WE EXPECT ro BE • WHERE WE ARE i! WHERE WE ARE WHERE we RE we WE ARE WH.ERE WE ARE 'ERE WE ARE we ARE RE Remain stable before and after opening a vial as indicated by the manufacturer WHERE we ARE WE WHERE we E WE ARE WE A RE WE ARE VE ARE A RE ARE WHERE we ARE WE WE ARE we ARE WHERE ARE What decisions made. decisions m is WE we analyzed repeatedly achons achons ±aKen WE WHERE WE ro BE ' WHERE WE A Re i WHERE RE i? WHERE WE ro WHERE WE ARE —WHERE WE WHERE WE ro ARE WHERE ARE w WHERE WE ARE WHERE WE ARE "ERE WE ARE WE ro WHERE WHERE WE WHERE we WHERE we ' WHERE WHERE we . WE ARE — Used to evaluate accura• WHERE WE ARE WHERE we A RE WHERE WRE WHERE WHERE W WHERE WHERE ARE WHERE we WHERE we WHERE ARE WE a RE WHERE RE 5 WHERE WE ARE WE EXPECT ro BE — Used to evaluatf — Used to WE ARE WHERE WHERE WHERE we ro WE , WHERE WE ARE we A RE WHERE WE ro BE WHERE wg WHERE WE roE WHERE WE ARE Pen or pe perform parallel testing in the order WHERE WE WHERE h WHERE WE EXPECT ro WHERE WE WHERE WE WE EXPECT ro BE' WE WHERE EXPECT WHERE we ARE we we WE WHERE WE ro WHERE WHERE WE EXPECT BE WHERE WE TO BE WHERE RE EXPECT TO BE' ro BE' — Used to evaluate accuracy a — Used to evaluate accuracy — Used to evaluate accura — Used to evaluate accuraly IJsed to evaluate accuracy a WHERE WHERE we A RE we PECT TO BE , WHERE WE ARE WE ARE — Used to evaluate accuracy and — Used to evaluate accuracy al — Used to evaluate accuracy at — Used to evaluate accure WHERE WE WE ro WHERE WE ARE — Used to evaluate accurac WHERE we ARE WHERE we ARE WHERE WE ARE WE ARE e WE ARE 'E EXPECr ro WHERE WE •;HERE we ARE WHERE we roE WHERE AR' Notepad d WHERE we ro WHERE WE ARE WHERE WRE WHERE we A RE WHERE we ARE WHERE we we ARE Pen or pencil WHERE we ARE +1 SD W ARE WHERE we ARE ro WHERE ARE WHERE ARE WC WHERE WE ARE WHERE WE A RE WHERE WE TOE — WHERE WE A RE WHERE RE WHERE WE ARe WHERE WE ro BE WHERE hE WHERE WE ARE WHERE WE e WHERE WE ARE we ARE Pen or pencil WHERE W RE WHERE WHERE WE roE • WHERE ARE WHERE WE WRE ! WHERE WE ARE WHERE WE ARE WHERE WE ARE .E WE ARE WHERE ARE we ARE WHERE we WHERE WRE WHERE WE ro BE WHERE WE ARE Sold with results of the — Sold with results of the WHERE WE EXPECT ro BE WHERE WHERE we ARE I , WE — Control values must be WE WHERE WE ARE WHERE WE ro Should ch Should dc Should di Should WE ARE WHERE ! WHERE WE ARE based on the stability of the procedure and the risk of based on the stability of the procedure al WHERE i WHERE WEARE WHERE WE List the steps as they unfold precision pencil WHERE WE EXPECr ro WHERE WE AHERE precision WHERE WE ARE WHERE WE AHERE WHERE WE ARE • WE ARE precision WHERE WE ARE WHERE we ARE WE we ARe WHERE WE u' WHERE WE ARE Pen or pencil MEAN QC used WHERE we levels presented during the role play — Reagents e did expect this QUALITY Use Of lyophilized ( controls WHERE we ARE QUALITY determined by the individual CONTROL We testing r WHERE Monitor the analytical phase only WHERE h — Avoid laboratc WHERE WEf during the role play — Avoid laboratory errors whu — Avoid laboratorx,errors v — Avoid laborator — Avoid laboratory errors whe only — Avoid manufacturer errors in — Avoid laboratory errors whet Avoid laboratory errors whe — Avoid laboratory errors — Avoid laboratory errors wh — Avoid laboratory errors wn — Avoid laboratory errors when — Avoid laboratory errors wne harm to the patient from an erroneous result. harm to the patient from an erroneous re C. CONTROL MENT past history of previous results CONTROL MEAN ey essayes Assayed QUALITY QUALITY QUALITY QUALITY n the n parallel the wtth the the point determining cc parallel (QC) determining co. Assigned MEAN (QC) SQC. to determ•ne if svstem stat•e undergo•nga determining control values determining control valles determining control Require availability Of clear determining control \ Calibration SD obs QUALITY SAMPLE 9 wi number laboratory without having the essayes (QC) (QC) assayed 16 minutes ot number currently mber currently Common formats used with — Common formats used with Common formats used CONTROL QUALITY C. QUALITY mENT manufacturer CONTROL CONTROL CONTROL. QUALITY SAMPLE CONTROL change CONTRCL ITROL rROL NOTE 1 The laboratory should choose concentrations of 1 tTIhe laboratory should ohoose CONTROL Messayes ve Aessayed essayes Messages essayes Mess:ges SAMPLE Should mimic patient samples — behave in the essayes 4 The accuracy .E AMPLE SAMPLE (QC) Assayed accuracy (QC) (QC) (QC) (QC aessayed (QC) (QC) SQC. guideline information from information rom CONTROL CONTROL (QC) CONTROL cor (QC) QUALITY C) What will you needo? What will you need? The accuracy and an The accuracy and The aocncy and ar AMPLE ey assayed SAMPLE The and an Assayed The accuracy an QUALITY Messages assayed package inserts essayes essaye€ SC SAMPLE (QC SS ayes accuracy and an — Expected (part of instrument maintenance assayed ess ages ee',ayes manufacturer accncy an accuracy Assayed ss -1 SD +1 SD ey analy+ic sys+em es SAMPLE SAMPLE Assayed SAMPLE ey essayes essayes SAMPLE*- Assayed The accuracy and an The accuracy and on CONT May experience more vial-to-vial variability (increase imprecision) if improper May experience more vial-to-vial variability (increase imprecision) especially if improper accuracy and (in o.ssages SAMPLE AMPLE (QC) IAMPLE control materials, wherever possible, especially at or control materials, wherever possible, es Shi-em es The (QC) CONTROL assayed sp+em es descri b es (QC) describes handling and reconstitution occurs rlENT the insert same manner (i.e. if patients results undergo a AMPLE b es SAMPLE The accuracy acid an Qruly±ic descra b es AMPLE Frequently has a shorter opened vial expiry interval Mean and ±2 SD range schedule) Shi-em describes WHERE WE Parallel Testing SAMPLE The CONTROL (QC) system The accuracy and The The accuracy Q and an The accuracy and •veclSton (QC) The accuracy L The accuracy and The accuracy and an The accumcy an The accu The accuracy and@qecÅSlon *hen The The accuracy accuracy accuracy The accuracy and Q The accuracy and The at-curacy an QtecÅSton accuracy WHERE wr Notepad and an ARE and near clinical decision values, which ensure the validity of near clinical decision values, which ens The accuracy aqd The accuracy uallfl& expensive than The accuracy and and The accuÄ The accuracy and an The The accurac SYB+•em WHERE WE ARE we ARE essayes WHERE WC The accuracy and@€ec'ßon WHERE Il less expensive than — Usually less expensive than +2 SD -2 SD -1 SD analy+ic sys Analytical analy he accuracy an ys+em descfl b es fem b es accuracy and an Mean and I SD Mean and ±2D Mean and 1 SD Mean and ISD sys+em descfib es shift, so should our QC results) fem descflbes sys+em es ic Shi-em describ es accuracy descftb e descrt b es sy*em descflb es pi-em b es Shi-em descflb es sys+em descfib es sys+em b es sys+em de sys+em Syså-em descrv syså-em desc Shi-em Syså-ev Sysfem describ fem describes fem describ es Shi-em es Shi-em descftbes syså-em descftbe descri b es SAMPLE sys+e des IS es sac: IS System es b. Eliminates many Of the handling and reconstitution errors b. many Of handling and and —Unexpected (a problem during testing is analy+i IS analyzed analy+ic sye Analytical Analy+ica\ OF Pen or pencil Q. Syså-em d sys+e sacs Sys+em descfl b es an Shi-em describes Sys+em descfl b sys+em b es Sysfem descrtb sys+em describ es Sys+e Sysfem descflb es OR System decisions made. RE WE ARE WHERE we ARE System b es sac:— QuiCK sys+em es Assayed assayed essayes Aessayed wr ARE WE ARE y WHERE WE WE ARE we WHERE WE ARE —WHERE WE — ARE WHERE WRE WHERE we ARE to WHERE WE ARE WHERE WE A RE WHERE A Re WE ARE WHERE WE ARE — WE WHERE w WHERE WE RE we RE WE we IS t; WHERE WHERE WHERE ARE ARE WHERE "e WHERE — Used to evaluate accuracy — Used to evaluate accuracy a — Used to evaluate accura sys+em describ es IS IS i. May discard or none Of product if consumed within opened expiry date The accuracy and and and anS ased WHERE we, WHERE ARE ' WHERE and WHERE WE A WHERE WE ARE WHERE and and and -sac:— We compare today's observed value with the The accucacy QC and WHERE WHERE WE WHERE Should detect changes at medical decision WHERE RE WHERE we ARE WHERE WE ARE WHERE WHERE WE A WHERE we m. Of lot number changes WHERE we we ARE WE we ARE WHERE we roE WHERE ARE we t; we The accuracy QCd The accuracy *hen parallel testing takes time and money (costs Of performing testing on QC is NOTE 2 Use of independent third party control and and precision precision — Used to evaluate precision and and WHERE 'IS IS fie analyiical IS IS Chart? WHERE WRE WHERE we IS IS —'WHERE WE EXPECr ro IS I S WHERE Is IS we EXPECT ro IS IS and WHERE he —'WHERE wk he I Ecr Analytical WHERE WE TOE we EXPECT ro D RE WE we WE we ro sp+em has WE EXPECT ro D IS With each QC material lot number change, lose access to summary or cumulative data chanse fie analy+ical sacs sis -sac: sac. IS Major component changed on the instrument basis OF we sacs System has occurs-ed. ARE nd past history of previous results has occuvced. - SQC. -oFEQC. sac: sac. sys+em Bas 'IS +hen has has occurted sac. sac: IS levels ) *hen IS the Chanee fie analy+ical only Goals —WHERE WE I WHERE we —WHERE B WHERE we ARE change fro the analyiical IS WHERE —WHERE WE —'WHERE we he analy+ical WE n WE E materials should be considered, either instead of, or in WE RE WE EXPECT ro B WE ro g IS — Avoid laboratory errors when aned i. Desired expiration date should be specified at time of purchase —WHERE WE — WHERE wk based on the stability of ty analy+ical a. change fro He analy•ical Change fro fie analy+ical Based on the past history change He analy+ical is Is Chanee he analy+ical is Is is no+ 'IS WHERE WHERE WE is is SQ is IS is is .1 is is no+ is IS Is ne+ WHERE WHERE WC ARE WHERe IS WHERE we i WHERE WE WHERE we ARC WHERE WE we WHERE RE IS WHERE we we we ARE we we ARC Re WE ARE we we ARC Sys+em Has WHERE WRE we is In parallel with the has occuvted. WHERE sacs WHERE we ' SF+em has occuvced. has occutted. chanse to fie an r roe he • Change in the testing Sys+em has occutted 'hanse to he to determine if the system is stable or undergoing a ) *hen change. hen IS determining control values — Avoid manufacturer errors in — Tested by manufacturer using — Avoid laboratory errors when {OAvoid manufacturer errors in — Tested by manufacturer usin *hen WE expecr +hen en ERE wk Expect Hhen ERE WE exp WHERE Wt of previous results addition to, any control materials supplied by the WE EXPECT R WHERE is +hen we wr WHERE ERE is ERE we +hen WHERE WE ARE i WHERE WE y WHERE WE WHERE we WHERE we WHERE ARE WHERE 'E WHERE WE A WHERE we ARE has occur?' 4) WHERE we ARE lot number currently WHERE WEf y WHERE WE WHERE has occutc Change fie a. change fro He analy•ical hanse fro analy+ical e fro fie analyiical fro fie anqlyiical Change o fie analy+ical has change fro fie change -to fie analy+icn change change fro -the analyiical change to fie amly+ica change +0 the analy+ia Chance the analyiical 'iica\ Change fie amlyiica a he analy+ica change. change fro fie anqlyiic„l change fie analy+ia change +0 fie analy+ica I change fro -fie analyiical change fie amilyiical change he analyiica C. change fro fie analy+ica change yo the analy+icn change o fie analy+ical —WHERE WE EXPECT Change Change fro the analyiica\ change anqly+ical fro fie analyiical ange fro fie analyiical nge analyiica\ e +0 fie analy+ical fro He analyiical +0 fie analy+ical +0 fie analyiica I fro fie analy+ica analy+ical analyzed change to the amly+ical change o fie analy+icnl Change fro fie I fro fie anqlyiicnl Change fie analy+ical change to fie analyiica change fro fie anqlyiicx IS e analy+ical fie analyiical -the analyiical Analytical -to fie analyiical ICal *hen ERE ro BE change determining control values ro +hen we WECXPECf ro —WHERE WE ro ange fie analyiica\ ge fie analyiical fie analyiical Ability to accommodate standing orders RE WC WE expect ro g , WHERE WE ARE reagent or instrument manufacturer. change. WHERE WE ro E —WHERE WE EXPECT ro BE Sys+em has occul SYS+em hange analy+ical SYS+em has 15 minutes sys+em has occuvced. Sys+em Sys+-em has occurced. sys+em has occurted. sys+•em has occur?ed. sys+em has occurced. m has occutfed. Sys+•em ha SYS+em h SYS+em hat sys+-em has occur? sys+em has occuvtced. sys+em has occuvted. System +0 analyiical d. Ability to sequester specified lot number and automatically ship and bill as outlined in the sys+em has occurced. has occuned. -m has occuvted. s occuvced. sys+em has occuvtfed. has occutfed. Sys+em has occunred. as occuvted. WC expect ro in-use as occuvced. occutfed. s occurced. occuvced. occuvted. Change naly+ica\ change. change fro fie analyiicai Analytical a change fie analy+iü Change Change fro the amaly+ical change amly+ical Change -to fie analyiical change hie analy+ica\ change fie analy+ical purchase agreement o. change fro he analy+ical Change analy+ical has occuvt em has OCCuvt WHERE we •u